A Phase I/II Study of Radiation Therapy, Paclitaxel Poliglumex and Cetuximab in Advanced Head and Neck Cancer
Phase 1/2 Completed
53 enrolled
Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer
Phase 3 Unknown
1,157 enrolled 15 charts
PIONEER
Phase 3 Terminated
600 enrolled
Polyglutamate Paclitaxel Compared With Gemcitabine or Vinorelbine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
Phase 3 Terminated
Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
Phase 3 Terminated
450 enrolled
Neoadjuvant Paclitaxel Poliglumex, Cisplatin and Radiation for Esophageal Cancer: A Phase II Trial (CTI#X64001)
Phase 2 Completed
40 enrolled 7 charts
PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation
Phase 2 Completed
63 enrolled 8 charts
CT-2103 in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Phase 2 Completed
78 enrolled
Neoadjuvant Doxorubicin, Polyglutamate Paclitaxel, Capecitabine and Metronomic Chemotherapy in Breast Cancer
Phase 2 Withdrawn
Paclitaxel Poliglumex and Estradiol in Treating Patients With Stage IV Prostate Cancer
Phase 2 Terminated
21 enrolled 8 charts
A Phase II Study of Radiation Therapy, Paclitaxel Poliglumex, and Carboplatin in Stage III Non-Small Cell Lung Cancer
Phase 2 Terminated
10 enrolled 11 charts
Paclitaxel Poliglumex and Capecitabine in Treating Patients With Metastatic Breast Cancer
Phase 2 Completed
48 enrolled
Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer
Phase 1 Completed
32 enrolled
A Pilot Study of PPX in Women With Metastatic Colorectal Cancer
Phase 1 Completed
15 enrolled
Phase II Study of Combination of Paclitaxel Poliglumex and Alimta for Advanced Non-small Cell Lung Cancer (NSCLC)
Phase 2 Completed
14 enrolled 8 charts
CT-2103 in Treating Patients With Recurrent Ovarian Epithelial or Fallopian Tube Cancer or Primary Peritoneal Cancer
Phase 1/2 Completed
CT-2103 in Combination With Gemcitabine in Metastatic Breast Cancer
Phase 1 Completed
13 enrolled
Phase II CT-2103/Carboplatin in Ovarian Cancer
Phase 2 Completed
82 enrolled
Study of Xyotax (CT-2103) in Patients With Metastatic Breast Cancer
Phase 2 Completed
45 enrolled